Patent 11851458 was granted and assigned to NovoBiotic Pharmaceuticals on December, 2023 by the United States Patent and Trademark Office.
The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.